NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC
NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID:MAJI), today announced that it has executed a definitive Letter of Intent (LOI) to acquire 100% of Xycota Biosciences, LLC ("Xycota"), a preclinical biotechnology platform engineering non-psychoactive, precision-targeted therapeutics to physically repair brain circuitry and restore synaptic connectivity.Xycota is advancing a transformative biological interface designed to physically repair...
Read more







